Table 4.
Gene defect | Protein function | Clinical Manifestation | Treatment |
---|---|---|---|
LRBA Loss of function | Assists in the vesicle trafficking and the turnover of the checkpoint of CTLA4 | splenomegaly and hepatomegaly, autoimmunity, manifesting as immune-mediated cytopenias and organ-specific autoimmunity, and chronic diarrhea | Abatacept |
CTLA4 Loss of function | An important regulator of T cell activation and mediator of regulatory T cell function | hypogammaglobulinemia, diarrhea/enteropathy, ILD, respiratory infections, lymphocytic organ infiltration, and splenomegaly | Abatacept |
STAT3 Gain of function | Transcription factor tightly controlled by numerous cytokines, growth factors, and hormones | autoimmunity, including autoimmune hemolytic anemia, autoimmune thrombocytopenia, enteropathy, and type 1 diabetes mellitus as well as lymphadenopathy and hepatosplenomegaly | Jakinibs and Tocilizumab |
PIK3CD Gain of function | Enzyme involved in growth and proliferation of white blood cells with potent affects upon B and T cell activation | recurrent respiratory infections and benign lymphoproliferation with bronchiectasis, GI disease, autoimmune cytopenias, glomerulonephritis, arthritis, and colitis | Rapamycin |
Adapted from the Current Understanding and Recent Developments in Common Variable Immunodeficiency Associated Autoimmunity10